Which drug inhibits the metabolism of metformin
Pro Research Analysisby 
Searched over 200M research papers
Drug Inhibition of Metformin Metabolism
Introduction to Metformin and Its Mechanisms
Metformin is a widely prescribed drug for the treatment of type 2 diabetes mellitus (T2DM). It primarily functions by inhibiting hepatic gluconeogenesis and improving insulin sensitivity. The drug's mechanisms involve the activation of AMP-activated protein kinase (AMPK) and inhibition of mitochondrial respiratory chain complex 1, which leads to alterations in cellular energy charge and redox state Foretz2019LaMoia2020Owen2000.
Metformin's Impact on Cellular Metabolism
Metformin exerts its effects by targeting various metabolic pathways. It inhibits anabolic processes such as gluconeogenesis and lipogenesis by activating the AMPK pathway and suppressing the steroid receptor coactivator 2 (SRC-2) . Additionally, metformin inhibits mTORC1 signaling in the liver, which is crucial for protein synthesis and cellular growth . These actions collectively contribute to the drug's glucose-lowering effects.
Drug Interactions Affecting Metformin Metabolism
One of the key interactions that inhibit the metabolism of metformin involves the mitochondrial respiratory chain complex 1. Metformin directly inhibits complex 1, leading to a decrease in mitochondrial oxidative phosphorylation and ATP production. This inhibition is time-dependent and results in the suppression of hepatic gluconeogenesis LaMoia2020Owen2000.
Conclusion
In summary, metformin's inhibition of mitochondrial respiratory chain complex 1 is a significant mechanism that affects its metabolism. This inhibition leads to decreased hepatic glucose production and improved peripheral glucose utilization, making metformin an effective treatment for T2DM. Understanding these interactions is crucial for optimizing therapeutic strategies and managing potential side effects.
Sources and full results
Most relevant research papers on this topic